CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • February 9th, 2021 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionThis Contingent Value Rights Agreement, dated as of _________, 20___ (this “Agreement”), by and among Seneca Biopharma, Inc., a Delaware corporation (“Parent”), [●], as CVR Agent (the “CVR Agent”), and [●], in [its/his/her] capacity as the initial CVR Holders’ Representative (the “CVR Holders’ Representative”).